Impact Therapeutics

Developer of small molecule therapeutics for the treatment of cancer

placeNanjing, Jiangsu, China calendar_todayFounded 2009 groups7 employees language impacttherapeutics.com

Innovation

40 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 832 times.

YearFilings
20154
20163
20173
20186
20197
202010
20218
20224
20237
20248
20256
20261

Investor mix

23 investors on record; lead investors include ShenZhen GTJA Investment Group, Xicheng Jinrui, Decheng Capital.

Investor typeCountShare
Venture capital1043%
Private equity835%
Angel & family office14%
Other / undisclosed417%
Coming soon